SRSS 016
Latest Information Update: 15 Apr 2004
At a glance
- Originator Sirus
- Class Analgesics; Nonsteroidal anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 11 Mar 2004 Discontinued - Preclinical for Pain in United Kingdom (Sublingual)
- 30 Jun 2003 Preclinical trials in Pain in United Kingdom (Sublingual)